Introduction
A prostaglandin antagonist would be a valuable tool in determining the involvement of prostaglandins in physiological and pathological processes, and it might also be of therapeutic value. Fried, Santhanakrishnan, Himizu, Lin, Ford, Rubin & Grigas (1969) synthesized several compounds, structurally related to the prostaglandins which had various degrees of antagonist activity against PGE1 on the longitudinal muscle of guinea-pig ileum, 'rabbit ileum and jird colon. The substance 7-oxa-13-prostynoic acid (compound 19396, Fig. 1 ) was reported to be relatively specific in these tissues, but Flack (1970) considered this to be true only in the jird colon. Sanner (1969) showed that the substance l-acetyl-2-(8-chloro-10,11-dihydrodibenz (b,f)(1,4) oxazepine-10-carbonyl) hydrazine (SC-19220, Fig. 1 ) specifically inhibited the contractions produced by PGE2 on guinea-pig ileum, but tests on other tissues or with other prostaglandins have not been reported. Eakins, Karim & Miller (1970) found that polyphloretin phosphate (PPP) antagonized PGE2-and PGFu-induced contractions of the isolated longitudinal muscle of the jird colon, rabbit jejunumn and rabbit uterus; the responses to several other agonists were unaffected. Lastly, fenamates were found to be of potential value as prostaglandin antagonists since they inhibited PGF2a on human isolated bronchial muscle (Collier & Sweatman, 1968) . We report studies of the activities and selectivities of compound 19396, SC-19220 and PPP against PGE2 and PGF2a on human, guinea-pig and rat isolated gastrointestinal smooth muscle.
Methods
Human gut muscle was obtained from operation specimens resected for a variety of diseases. The material was obtained immediately after surgery and was studied the same day, or on the following day after storage at 40 C. The mucosa and submucosa were removed and strips of muscle 2-3 cm long and 2-3 mm wide were cut parallel to the longitudinal or circular layers. Smooth muscle preparations from guinea-pigs and rats were obtained after the animals were stunned and bled. Whole segments of intestine 2-3 cm long were used to study the longitudinal muscle, whereas the circular muscle preparations (guinea-pig colon 6-15 cm from the anus) were obtained by cutting a shallow spiral. Strips of rat fundus were prepared according to Vane (1957) . The preparations were suspended under a load of 05-1 g in Krebs solution at 370 C, bubbled with 5% CO2 in 02. The movements of the muscle were recorded on a kymograph by an isotonic frontal writing lever with a magnification of 8-12. Because the antagonists often caused a reduction in tone, the relaxant effects of the prostaglandins were usually assessed by the inhibi-/{^0 (CH2)5COOH tion of responses to potassium chloride (10-2 to 3 x 10-2M) or to acetylcholine. The specificity of prostaglandin block was determined by measuring the effect on contractions produced by a constant dose of acetylcholine or, sometimes, of other agonists.
Drugs
The drugs used were 1-acetyl-2-(8-chloro-10,11-dihydrodibenz (b,fX1,4) oxazepine-10-carbonyl) hydrazine (SC-19220) , acetylcholine chloride, histamine hydrogen tartrate, 5-hydroxytryptamine creatinine sulphate (5-HT), nicotine hydrogen tartrate, 7-oxa-13-prostynoic acid (compound 19396) , polyphloretin phosphate (PPP), potassium chloride and prostaglandins E2 and F2a (PGE2 and PGF2a). SC-19220 was dissolved either in propylene glycol (1 mg/ml) or ethyl alcohol (10 mg/ml). The prostaglandins and compound 19396 were dissolved in ethyl alcohol (10 mg/ml) and diluted to 1 mg/ml with 0 9% w/v NaCl containing sodium carbonate (0-2 mg/ml). PPP was dissolved in water (100 mg/ml) and the pH adjusted to 7-0 with sodium carbonate. Fleshler & Bennett, 1969; Bennett, 1970; Bennett & Fleshler, 1969 . There have been no previous reports of the effects of PGE2 and PGFB. on the human ascending colon, and the responses of human stomach muscle to PGF, have been referred to only as unpublished data (Bennett & Fleshler, 1970) . Since the longitudinal muscle of the gut is usually contracted by PGE2, whereas the circular muscle is inhibited ( Compound 19396 This substance did not block prostaglandins selectively in any tissue. It produced dose dependent contractions of the rat stomach.
Human (longitudinal muscle of gastric body and terminal ileum; circular muscle of gastric body and sigmoid colon). Compound 19396 (at least 5 5 x 10-5M in each experiment, and up to 3 x 10-4M in some instances) either had little or no effect on responses to prostaglandins, or at the higher concentrations it depressed the responses to acetylcholine as well as to prostaglandins (Fig. 2) . Compound 19396 usually reduced the tone of intestinal preparations but increased the tone of gastric circular muscle strips, whilst that of longitudinal gastric muscle was virtually unaffected.
Guinea-pig (longitudinal muscle of ileum; circular colonic muscle). Compound 19396 (2 to 8 x 1O-5M) inhibited contractions of the longitudinal muscle of the ileum to acetylcholine, nicotine, histamine and PGE2. The colonic circular muscle which, in contrast to the longitudinal muscle of the ileum, has a resting tone, was relaxed by compound 19396 (2 to 8 x 10-5M). The highest concentration of antagonist (8 x 10-5M) reduced the contractions produced by acetylcholine, PGF2a and potassium. The effects on tone and the responses to agonists were partly due to the ethanol used in preparing the solution. A slight degree of selectivity was seen at lower concentrations (compound 19396, 2 to 4 x 10-5M): in three of four experiments the responses to PGFI,, were reduced by 20-50% without change in the response to acetylcholine. There was no selective blockade of the inhibitory effects of PGE. on maintained submaximal contractions to KCI.
Rat (stomach strip). Compound 19396 (3 x 10-6 to 8 x 10-SM) caused dosedependent contractions of the rat fundus (Fig. 3) . When the compound was kept in contact with the tissue (up to 30 min) the contraction was maintained. Neither PGE2 nor PGFIG was antagonized when added in the presence of a submaximal stimulating concentration of compound 19396 or after its removal from the bath when the tissue had relaxed (Fig. 3) .
Compound SC-19220 This substance specifically antagonized the excitatory effects of PGE2 and PGF2a in guinea-pig and rat tissues, but not in human tissues. It did not antagonize the inhibitory effects of PGE2.
Human (longitudinal muscle of gastric body, terminal ileum and sigmoid colon; circular muscle of gastric body). SC-19220 (7-5 x 10-6M to 1-5 x 10-'M) either had little or no effect on contractions produced by PGE2 and PGF2a, or it reduced the responses to both acetylcholine and the prostaglandins; this non-selective inhibition 7-5 x 10-5M) was there any evidence of a preferential block; the effect of PGE2 was almost abolished, whereas responses to acetylcholine and PGF2a were reduced by about 60%. SC-19220 reduced the tone of the muscle strips, and with large amounts of the antagonist the solvent propylene glycol used in preparing the solution added to this lowering of tone and to the general depression of responses to agonists.
Guinea-pig (longitudinal muscle of the ileum; circular colonic muscle). Cumulative log dose-response curves to PGE2 and to PGF2a on the longitudinal muscle of the ileum were shifted to the right in parallel by SC-19220 5 x 10-6 to 10-5M; Fig. 4) . With concentrations of antagonist up to 10-5M responses to acetylcholine and the maximum contractions to the prostaglandins were constant. Straight lines were obtained for plots of -log concentrations of SC-19220 against log (dose ratio-1), and the pA2 of SC-19220 against PGE2 and PGF2, was 5-6 and 5 5, respectively.
When the drug was washed out of the bath after being in contact with the tissue for 15 min, responses to prostaglandins returned to normal in 10 minutes. A longer exposure to the antagonist prolonged this reversal.
The contractions of the colonic circular muscle to PGF2a were inhibited by SC-19220 (10-5M). Responses to acetylcholine were unialtered or, possibly because SC-19220 lowered the tone of the muscle, were even larger. The degree of antagonism was therefore probably greater than calculated, since reduction of the tone with a lower concentration of SC-19220 (5 x 10-6M) increased the response to PGF2a. The antagonist also reduced the contractions to KCI, so that up to twice the amount of the salt was required to elicit contractions equal to control responses. SC-19220 did not reduce the inhibition of KCI responses by PGE2.
Rat (stomach strip). The tone of rat fundus preparations was reduced by SC-19220 in a dose-dependent manner (Fig. 5) . SC-19220 (5 x 10-5M) also blocked the responses to PGE2 and PGF2a and the cumulative log dose-response curves were shifted to the right in parallel. The contractions produced by acetylcholine were increased, presumably because tone was reduced, and again the degree of prostaglandin antagonism was probably greater than apparent. The tone of the fundus could be greatly reduced by frequent and regular dosing with prostaglandin and by increasing the load. Under these conditions SC-19220 did not further reduce the tone and responses to prostaglandins were inhibited with no alteration of responses to acetylcholine. Polyphloretin phosphate (PPP) PPP antagonized the excitatory effects of prostaglandins on most of the tissues studied, but caused stimulation of the rat fundus. High concentrations were required to block the effects of prostaglandins on human gastrointestinal muscle. In general, there was no antagonism of inhibitory responses to PGE2.
Human (longitudinal and circular muscle of gastric body and sigmoid colon; circular muscle of ascending colon). The tone and spontaneous activity of all tissues were reduced gradually over a period of approximately 2 h by PPP in concentrations of 100-1,200 ,ug/ml, and in some cases by as little as 25 jug/ml. At the lower concentrations the contractions to PGE2 and PGF2 were often increased, probably because of the reduction of tone. However, at 600 yg/ml, PPP inhibited the prostaglandins without affecting responses to acetylcholine, and up to 20-fold increases in the concentration of the prostaglandins produced only small or moderate responses. Only with the highest concentration of PPP used (1,200 jug/ml) were the responses to acetylcholine slightly reduced. As with the effect on tone, the blockade took up to 2 h to equilibrate; a similar period was required to reverse these effects after washing out the drug.
The inhibitory responses of the circular muscle of gastric body and of sigmoid colon to PGE2 (assessed by the reduction of submaximal contractions to constant doses of acetylcholine), were not blocked by 200 ,ug/ml). Indeed, it was sometimes found that at the highest concentration of PPP the PGE2 inhibition of acetylcholine contractions was greatly prolonged (tested up to 40 min).
As seen in Table 1 , the responses of the circular muscle of the ascending colon to far, inhibitory responses to PGFia sometimes occurred. In contrast to PGE2, the inhibitory responses to PGF2,1 were prevented in each case by PPP (250 jig/ml; Fig. 6 ).
Guinea-pig (longitudinal and circular colonic muscle). The results were qualitatively similar to those obtained with the human tissues. Tone was generally reduced, but in a few instances this wuas preceded by a small increase. The contractile responses to the prostaglandins were inhibited by PPP (50-300 ltg/ml for longitudinal muscle, and 200-300 jug/ml for circular muscle), whereas responses to acetylcholine were either unaffected or increased when the tone was lowered. As with compound 19396 and SC-19220, the responses to KC1 were usually reduced. In only two of seven experiments was there any indication of an antagonism of the inhibitory effects of PGE2.
Rat (stomach strip). PPP (20-100 jug/ml) caused small dose-dependent contractions of the rat fundus which were maintained when the drug was kept in contact with the tissue. However, the maximal responses obtained with PPP were small compared with those to prostaglandins or 5-HT. Contractions to prostaglandins or 5-HT superimposed on the PPP-induced contractions were either unaffected or, 10 min perhaps because of the increased tone, were slightly reduced. Higher concentrations of PPP (200-2,000 jug/ml) lowered the tone of the rat fundus and reduced the effects of 5-HT as well as PGE2 and PGF2,a.
Discussion
The three compounds tested for their activities as prostaglandin antagonists had varying effects on different tissues. Where a block did occur, this could not have been caused by chemical interaction with prostaglandins since there were several tissues in which no antagonism was observed. Absence of antagonism (for example with SC-19220 and compound 19396 on human tissues) might be attributable to insufficient drug concentrations. Larger amounts could not be tested because of the general depressant effects of the organic solvents. This emphasizes the need for more water soluble and more potent antagonists.
The experiments with compound 19396 are essentially an extension of the studies of Fried et al. (1969) and those of Flack (1970) . Some of the tissues used in our studies were different, and we studied PGE2 and PGF2a instead of PGE1. In addition to finding that compound 19396 is a non-selective antagonist in many animal tissues (jird colon is the only known exception ; Flack 1970 ), it appears to be almost ineffective on human gut muscle. The ability of the compound to excite rat fundus and the circular muscle from the body of the human stomach disagrees with the conclusions of Fried et al. (1969) that only analogues with a C15-OH group have agonist activity.
Compound SC-19220 and PPP, on the other hand, were fairly selective antagonists for PGE2 and PGF2a in a variety of tissues. These results agree with and extend the findings of Sanner (1969) , Eakins et al. (1970) and Eakins (personal communication) . The competitive nature of the antagonism of PGE2 and PGF2a with SC-19220 in guinea-pig ileum and in rat fundus is suggested by the shift of the log dose-response curves in parallel to the right. Furthermore, the data from guinea-pig ileum produce straight lines on plotting -log concentration of SC-19220 against log (dose ratio-1). Arunlakshana & Schild (1959) pointed out that if two agonists act on the same receptors they can be expected to be antagonized by the same antagonist. If the blockade is competitive, the same concentration of the antagonist will be effective in each case. Similar dose ratios were obtained at the 50% maximal response for both prostaglandins with each concentration of SC-19220, and almost identical pA2 values were produced. It is therefore possible that in the longitudinal muscle of the guinea-pig ileum, PGE2 and PGF2a act at a common receptor site.
By contrast, in circular muscle where PGE, causes relaxation and PGF2a produces contraction, the receptor sites for the two prostaglandins must be different. Furthermore, the inhibitory receptors for PGE2 in circular muscle appear to be different from the excitatory receptors for PGE2 in the longitudinal muscle, since only the latter are susceptible to block by SC-19220 and PPP. Lastly, with regard to differentiation of receptors, the inhibitory effect of PGF2a in the circular muscle of human ascending colon appears to involve a different site from that at which PGE2 produces relaxations since only PGF2a is blocked by PPP.
All three compounds had two properties in common. First, they reduced the contractions to KCI in concentrations which did not inhibit the effect of acetylcholine. The reason for this is not apparent, but it is interesting that there have been several reports that the responsiveness of tissues to prostaglandins are altered by changes in K+ concentration. Thus the inhibitory effect of prostaglandins on human isolated myometrium is potentiated by a reduction in the extracellular K+ concentration (Bygdeman & Eliasson, 1963) , and the response of rat fundus to PGE1 is greater when the concentration of potassium in the bathing fluid is increased (Coceani & Wolfe, 1966) . Second, the antagonists lowered the tone of most tissues. One possible explanation of this phenomenon is that prostaglandins might contribute to the maintenance of tone within some smooth muscles. Such a view is consistent with the correlation between prostaglandin release and the degree of tone in bovine isolated sphincter pupillae (Posner, 1970) . However, in some gut preparations the tone was lowered without any reduction in response to prostaglandins. Furthermore, both PGE2 and PGF2a may inhibit human colonic circular muscle, so that if these substances are released intrinsically their antagonism would be expected to raise the tone.
The variation in potency of the antagonists in different tissues is interesting but poses several problems. At the simplest level, the right antagonist must be chosen for each tissue, and compounds intended for clinical application should be screened on human material, at least until a suitable animal model is found. Although it is clear that none of the substances used in this study is a universally satisfactory prostaglandin antagonist, for certain experimental purposes both SC-19220 and 
